Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

7.70USD
24 Apr 2018
Change (% chg)

-- (--)
Prev Close
$7.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,418
52-wk High
$17.33
52-wk Low
$6.65

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

People

Name Age Since Current Position

Roger Pomerantz

60 2014 Chairman of the Board, President, Chief Executive Officer

Eric Shaff

42 2018 Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer

John Aunins

56 2012 Chief Technology Officer, Executive Vice President - Bioprocess and Manufacturing

David Cook

59 2012 Chief Scientific Officer, Executive Vice President - Research & Development

Thomas DesRosier

62 2016 Chief Legal Officer, Executive Vice President and Secretary
» More People

Seres Therapeutics Inc News

» More MCRB.OQ News